Hospital Acquired Infection Control Market - Growth, Trends, and Forecast (2020 - 2025)

October 2020 •
124 pages •
Report ID: 5826224 •
Format: PDF

Summary
Table of contents
Search Inside

The hospital acquired infection control market is expected to witness a CAGR of 7.3% during the forecast period. Certain factors that have been driving the market growth include the increase in hospital stay due to chronic diseases and surgeries, a rise in the incidences of different types of hospital-acquired infections, and innovative technologies implemented in devices that control infection.

- Hospital acquired infections are usually caused by pathogens, which spread at a very fast rate in the body. Due to the patients’ weak immune system and poor conditions in a hospital, the infections spread at a greater speed than the normal infections.
- These infections have been treated by taking antibiotics, by following a proper and healthy diet, and by encouraging the natural healing process. The infection can be prevented by keeping the hospital facility premises clean.
- The most common type of hospital acquired infections is a urinary tract infection. The increase in incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection, awareness regarding the use of personalized medicines, and cost-effective drugs to treat hospital-acquired infections are some of the factors that have been driving the growth of the studied market.

Key Market Trends
Disinfectant is Expected to Hold Significant Market Share in the Product Type

Disinfection is referred to as a process, which eliminates many or all pathogenic microorganisms, except the bacterial spores from inanimate objects. This is accomplished by the use of liquid chemicals or wet pasteurization. The efficiency of disinfection has been affected by several factors, each of which may limit the efficacy of the process. Some of the factors, which have been shown to affect disinfection efficacy are the earlier cleaning of the object, the organic load on the item, the type and level of microbial impurity, the physical configuration of the object (e.g., crevices, hinges, and lumens), the concentration of exposure time to the germicide, and the pH and temperature of the disinfection process. The US FDA (Food and Drug Administration) maintains a list of high-level disinfectants that can be used to reprocess heat-sensitive medical devices, such as flexible endoscopes.

North America Dominates the Market and Expected to do Same in the Forecast Period

According to the Centers for Disease Control and Prevention (CDC), even though significant progress has been made in stopping some healthcare-associated infection types from spreading, there is still much more work to be done. On any given day, in the United States, around one in 31 hospital patients has at least one healthcare-associated infection. North America, especially the United States and Canada, has made significant progress toward the collective goal of abolishing these HAIs, and as a result, healthcare in this region has become safer now than it was even 10 years ago. Building upon this success and continuing toward the elimination of hospital-acquired infections is critical, and this has contributed to the largest market share of North America.

Competitive Landscape
The hospital acquired infection control market is highly competitive and consists of several players. Companies, like 3M Company, Becton, Dickinson and Company, Belimed AG, Biomerieux Sa, Cantel Medical, Ethicon, Getinge Group, Kimberly-Clark Corporation, Sterigenics International LLC, and Steris Corporation, among others, hold the substantial market share in the hospital acquired infection control market.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

Ahmad helps you find the right report:

+1 718 618 4302
Contact by email

FAQ

Testimonials

The market research advisor answered my questions quickly and professionally. ReportBuyer's team did their best to ensure that I felt comfortable before making the investment to purchase the report.

Cristian Nunez

Director of Corporate Development Chugach Alaska Corporation

My overall experience with ReportBuyer today has been very positive, and I must thank you for your patience (...). Also, the sample you sent me and the explanations provided were very helpful.

D. Lescuyer

Executive Vice President Oral Business at Skyepharma

The research specialist was very helpful, and proposed the best content for my needs. ReportBuyer also offered a great follow-up, thanks for everything !

P. Thompson

EMEA Managing Director

We were satisfied with the support that ReportBuyer's team provided. Thanks to their recommendations, the report we purchased provided exactly what we want.

Y. Wang

Business Analyst

We didn't have time to do the research internally, and thanks to ReportBuyer's team we were able to find the appropriate data.

S. Chen

Research Coordinator

I was impressed by the customer service: it was fast, responsive, and 100% professional !

D. Krivan

Market Research Analyst

The research specialist provided prompt and helpful service. He also followed up to ensure I had all the information to deliver my business development plan.

C. Adams

Senior Business Development Manager